198.32MMarket Cap-2865P/E (TTM)
7.4600High7.1000Low267.31KVolume7.2700Open7.3400Pre Close1.94MTurnover1.41%Turnover RatioLossP/E (Static)27.36MShares9.010052wk High13.38P/B137.65MFloat Cap2.711752wk Low--Dividend TTM18.99MShs Float171874.8797Historical High--Div YieldTTM4.91%Amplitude2.1900Historical Low7.2440Avg Price1Lot Size
Abeona Therapeutics Stock Forum
Upcoming Cell & Gene Therapy PDUFA’s in 2024
Abeona Therapeutics ($Abeona Therapeutics(ABEO.US)$ )
Asset: Pz-cel (prademagene zamikeracel)
PDUFA Date: May 25, 2024
Indication: Recessive dystrophic epidermolysis bullosa (RDEB)
Technology: Autologous cell therapy, treatment uses gene transfer to deliver COL7A1 genes into an RDEB patient’s own skin cells then transplanting them back to the patient.
Rocket Pharmaceuticals ($Rocket Pharmaceuticals(RCKT.US)$ )...
totally called it a while ago
finally broo I feel like that free at last song after a 3 year miserable hold
looks good
talk about spicy Jesus
Update
2 MINUTES AGO, 7:30 AM EST
VIA GLOBENEWSWIRE
On track for PDUFA target action date of May 25, 2024 -
Update
3 MINUTES AGO, 7:30 AM EST
VIA GLOBENEWSWIRE
UPDATE!
No comment yet